806 filings
Page 11 of 41
8-K
LEXX
Lexaria Bioscience Corp
14 Jan 21
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
5:13pm
10-Q
2021 Q1
LEXX
Lexaria Bioscience Corp
Quarterly report
14 Jan 21
3:57pm
424B4
LEXX
Lexaria Bioscience Corp
14 Jan 21
Prospectus supplement with pricing info
12:00am
EFFECT
LEXX
Lexaria Bioscience Corp
12 Jan 21
Notice of effectiveness
12:15am
S-1MEF
LEXX
Lexaria Bioscience Corp
11 Jan 21
Registration of additional securities for an S-1
9:25pm
CERT
LEXX
Lexaria Bioscience Corp
11 Jan 21
Certification of approval for exchange listing
10:10am
8-A12B
LEXX
Lexaria Bioscience Corp
11 Jan 21
Registration of securities on exchange
9:01am
S-1/A
LEXX
Lexaria Bioscience Corp
IPO registration (amended)
7 Jan 21
4:02pm
CORRESP
LEXX
Lexaria Bioscience Corp
7 Jan 21
Correspondence with SEC
12:00am
CORRESP
LEXX
Lexaria Bioscience Corp
7 Jan 21
Correspondence with SEC
12:00am
S-1/A
LEXX
Lexaria Bioscience Corp
IPO registration (amended)
6 Jan 21
6:09am
8-K
LEXX
Lexaria Bioscience Corp
31 Dec 20
Regulation FD Disclosure
5:07pm
8-K/A
LEXX
Lexaria Bioscience Corp
31 Dec 20
Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets
1:57pm
8-K
LEXX
Lexaria Bioscience Corp
22 Dec 20
Regulation FD Disclosure
3:16pm
8-K
LEXX
Lexaria Bioscience Corp
10 Dec 20
Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets
12:19pm
8-K
LEXX
Lexaria Bioscience Corp
2 Dec 20
Lexaria’s Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs
1:24pm
UPLOAD
LEXX
Lexaria Bioscience Corp
23 Nov 20
Letter from SEC
12:00am
S-1
LEXX
Lexaria Bioscience Corp
IPO registration
19 Nov 20
9:44pm
8-K
LEXX
Lexaria Bioscience Corp
19 Nov 20
Entry into a Material Definitive Agreement
4:29pm
DRS
LEXX
Lexaria Bioscience Corp
13 Nov 20
Draft registration statement
12:00am